SAN DIEGO--(BUSINESS WIRE)--Novocell, Inc., a stem cell engineering company, today announced it has entered into a non-exclusive drug discovery collaboration with Pfizer giving Pfizer access to Novocell’s proprietary pancreatic progenitor cells derived from human embryonic stem (hES) cells.
